Latest News & Features
Americas
The strongest cannabidiol patent portfolios are owned by Roche, Boehringer Ingelheim, and AbbVie, according to a report released earlier this week. 9 November 2018
Biotechnology
The European Patent Office has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier. 9 November 2018
Americas
Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923. 8 November 2018
Big Pharma
The Swiss Federal Institute of Intellectual Property has issued a notice covering a change in the practice for granting supplementary protection certificates (SPCs), following a landmark decision by Switzerland’s highest court. 8 November 2018
Americas
Womble Bond Dickinson has strengthened its Boston-based life sciences team with the addition of patent attorney Briana Erickson. 7 November 2018
Americas
Generic makers Teva, Mylan and Akorn asked the US Court of Appeals for the Federal Circuit not to stay to its sovereign immunity ruling pending an appeal by Allergan and the Saint Regis Mohawk Tribe to the US Supreme Court. 7 November 2018
Americas
Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company. 7 November 2018
Big Pharma
Germany’s Federal Patent Court has published the reasoning behind its decision to revoke Gilead Sciences’ supplementary protection certificate for HIV/AIDS treatment Truvada, 6 November 2018
Americas
Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report. 6 November 2018
Big Pharma
HGF has strengthened its Basel, Switzerland office with the addition of Leena Contarino as a partner. 5 November 2018